Enhancing Enrollment for NOD and DETECT studies of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
$192,088U01FY2019DKNIH
Stanford University, Stanford CA
Investigators
Linked publications, trials & patents
Paper 39137098Paper 38583544Paper 38461145Paper 38451604Paper 38423226Paper 38284831Paper 38047728Paper 37451493Paper 37436452Paper 37061168Paper 36404274Paper 36395395Paper 36382801Paper 36191836Paper 36149018Paper 35857066Paper 34571258Paper 33060628Paper 32973069Paper 32798493Paper 32493828Paper 32285180Paper 31791885Paper 31688587Paper 31089778Paper 30973461Paper 30705050Paper 30660726Paper 30325864Paper 30325863Paper 30325862Paper 30325859Paper 30325281Paper 29702529Paper 28941651Paper 28919082Paper 28523572Paper 28404095Paper 28272465Paper 27341355
Abstract
Project Summary/Abstract The Stanford Unit is part of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreas Cancer (CPDPC), which has 4 signature protocols including the PROCEED, INSPIRRE2, DETECT, and NOD study. Our Clinical Center has actively enrolled participants in all 4 studies. The purpose of this administrative supplement request is to increase enrollment primarily in the NOD and secondarily in the DETECT studies by adding an additional full-time Clinical Research Coordinator to boost enrollment of participants and a part-time Laboratory Science Technician to help process and bank samples according to the current protocols.
View original record on NIH RePORTER →